Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | (Q3)Sep 30, 2015 | (Q2)Jun 30, 2015 | (Q1)Mar 31, 2015 | (FY)Dec 31, 2014 | (Q4)Dec 31, 2014 | (Q3)Sep 30, 2014 | (Q2)Jun 30, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 51.37%-4.67M | -91.37%1.87M | -221.98%-3.47M | 598.05%8.99M | -63.64%5.96M | -325.35%-9.61M | 3.39%21.63M | 152.16%2.85M | -132.85%-1.81M | 86.89%16.38M |
Net income from continuing operations | -67.34%-24.62M | -349.40%-51.62M | -525.99%-15.26M | -148.44%-12.86M | -25.59%-8.79M | -570.17%-14.71M | -1,256.27%-11.49M | -40.71%-2.44M | -39.89%-5.18M | -81.27%-7M |
Operating gains losses | 316.04%714.2K | -193.60%-454.84K | -1,578.92%-123.79K | 22.82%328.52K | -147.74%-328.98K | -48.75%-330.59K | -1,105.58%-154.92K | 96.13%-7.37K | 365.59%267.49K | -124.51%-132.79K |
Depreciation and amortization | -12.89%4.62M | -6.58%21.4M | 2.86%5.2M | 0.49%5.45M | -20.41%5.44M | -5.05%5.3M | 6.06%22.91M | -0.89%5.06M | -1.47%5.42M | 19.10%6.84M |
Deferred tax | -100.01%-543 | 316.08%9.36M | 264.37%472K | --0 | 79.49%-298.18K | 703.04%9.18M | -653.62%-4.33M | 72.52%-287.16K | -211.00%-1.07M | -250.47%-1.45M |
Other non cash items | 63.18%972.08K | 44.29%2.59M | 139.47%852.07K | 12.37%551.24K | 15.41%591.93K | 36.51%595.72K | 14.22%1.8M | -18.78%355.81K | 22.08%490.57K | 51.54%512.9K |
Change In working capital | 101.48%139.05K | -52.64%4.58M | 130.92%901.3K | 412.70%5.63M | -57.23%7.47M | -205.98%-9.42M | 268.48%9.67M | 66.94%-2.91M | -181.51%-1.8M | 285.27%17.46M |
-Change in receivables | 66.38%-2.09M | -135.83%-4.33M | 7.34%-2.68M | -172.07%-1.61M | -75.38%6.18M | 49.61%-6.22M | 587.40%12.1M | 74.51%-2.9M | 226.49%2.23M | 18.90%25.1M |
-Change in payables and accrued expense | 262.22%2.65M | 172.70%6.68M | 442.73%2.04M | 260.67%5.7M | 109.62%573.97K | -277.46%-1.63M | -412.07%-9.19M | -110.21%-594.19K | -220.87%-3.55M | 56.72%-5.97M |
-Change in other current assets | 163.17%474.73K | -70.94%2.27M | 309.08%1.15M | 146.67%1.24M | -27.74%626.88K | -112.23%-751.5K | 242.39%7.79M | 106.76%280.63K | 1,206.80%503.34K | 148.93%867.55K |
-Change in other current liabilities | -9.83%-892.33K | 96.99%-31.14K | 35.59%400.85K | 129.85%295.28K | 103.35%85.19K | -136.84%-812.47K | -42.38%-1.03M | -66.37%295.63K | 31.83%-989.09K | 19.06%-2.55M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 51.37%-4.67M | -91.37%1.87M | -221.98%-3.47M | 598.05%8.99M | -63.64%5.96M | -325.35%-9.61M | 3.39%21.63M | 152.16%2.85M | -132.85%-1.81M | 86.89%16.38M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 120.45%149.62K | 99.42%-161.34K | 90.30%-448.59K | 150.38%1.44M | 90.67%-421.78K | 95.41%-731.6K | -105.56%-27.96M | -252.80%-4.63M | 33.56%-2.86M | 21.72%-4.52M |
Net PPE purchase and sale | 120.45%149.62K | 99.42%-161.34K | 90.31%-448.59K | 150.39%1.44M | 90.67%-421.78K | 95.41%-731.6K | -105.61%-27.96M | -253.30%-4.63M | 33.56%-2.86M | 21.70%-4.52M |
Net intangibles purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 72.30%-131 | 56.47%-1.03K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 120.45%149.62K | 99.42%-161.34K | 90.30%-448.59K | 150.38%1.44M | 90.67%-421.78K | 95.41%-731.6K | -105.56%-27.96M | -252.80%-4.63M | 33.56%-2.86M | 21.72%-4.52M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -58.59%4.07M | -1,628.79%-3.52M | 9.21%3M | -2,933.85%-9.32M | 32.42%-7.04M | 27.61%9.84M | 97.08%-203.76K | -47.96%2.75M | -138.51%-307.29K | -218.78%-10.41M |
Net issuance payments of debt | -61.68%3.98M | -166.15%-1.72M | 8.89%3.01M | -3,539.57%-8.65M | 24.47%-6.48M | 27.34%10.4M | 158.30%2.61M | -51.81%2.77M | -79.29%251.58K | -217.05%-8.58M |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | ---- | ---- | --60K | --0 | --0 | ---- |
Net other financing activities | --775.53K | ---- | ---- | ---- | ---- | ---- | -49.78%-1.39M | 246.63%21.99K | -4,322.38%-61.25K | -562.41%-1.35M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -58.59%4.07M | -1,628.79%-3.52M | 9.21%3M | -2,933.85%-9.32M | 32.42%-7.04M | 27.61%9.84M | 97.08%-203.76K | -47.96%2.75M | -138.51%-307.29K | -218.78%-10.41M |
Net cash flow | ||||||||||
Beginning cash position | -35.85%2.36M | -62.18%3.68M | 23.99%3.18M | -74.28%1.9M | -43.33%3.47M | -62.18%3.68M | 9.92%9.73M | -76.56%2.56M | -18.80%7.38M | -32.80%6.12M |
Current changes in cash | 10.70%-450.04K | 72.18%-1.82M | -195.60%-923.33K | 122.31%1.11M | -203.44%-1.5M | 87.32%-503.96K | -2,057.49%-6.53M | 164.68%965.87K | -349.74%-4.97M | 625.06%1.45M |
Effect of exchange rate changes | -118.30%-53.28K | 3.19%498.47K | -29.23%107.54K | 10.26%168.72K | 63.07%-68.91K | -20.17%291.13K | -11.20%483.06K | -48.50%151.96K | 199.60%153.01K | -170.83%-186.58K |
End cash Position | -46.43%1.86M | -35.85%2.36M | -35.85%2.36M | 23.99%3.18M | -74.28%1.9M | -43.33%3.47M | -62.18%3.68M | -62.18%3.68M | -76.56%2.56M | -18.80%7.38M |
Free cash flow | 54.95%-4.7M | 94.61%-401.31K | -46.04%-3.95M | 278.81%8.61M | -54.64%5.37M | 10.85%-10.43M | -213.81%-7.45M | 59.35%-2.7M | -669.51%-4.82M | 342.38%11.83M |
Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |